Advertisement

Clinical Oral Investigations

, Volume 14, Issue 5, pp 525–531 | Cite as

Clinical effects of nanocrystalline hydroxyapatite paste in the treatment of intrabony periodontal defects: a randomized controlled clinical study

  • Bernd Heinz
  • Adrian Kasaj
  • Marie Teich
  • Søren JepsenEmail author
Original Article

Abstract

The purpose of the present randomized controlled clinical study was to compare the clinical outcomes of papilla preservation flap surgery with or without the application of a novel nanocrystalline hydroxyapatite (nano-HA) bone graft substitute. Fourteen patients with paired intrabony periodontal defects of ≥4 mm participated in this split-mouth design study. The defects in each subject were randomly selected to receive nano-HA paste in conjunction with papilla preservation flaps or papilla preservation flaps alone. Probing bone levels (PBL) from a customized acrylic stent and probing pocket depths (PPD) were measured at baseline and again 6 months following surgery. No differences in any of the investigated parameters were observed at baseline between the two groups. Healing was uneventful in all patients. Both treatments resulted in significant improvements between baseline and 6 months (p < 0.05). At 6 months after therapy, the sites treated with nano-HA paste showed a reduction in mean PPD from 8.3 ± 1.2 to 4.0 ± 1.1 mm and a gain in PBL of 4.3 ± 1.4 mm, whereas in the control group, the mean PPD changed from 7.9 ± 1.2 mm to 5.0 ± 1.2 mm and PBL gain was 2.6 ± 1.4 mm. Results demonstrated statistically greater PPD reduction and PBL gain (p < 0.05) in the test group as compared with the control group. In conclusion, after 6 months, the treatment of intrabony periodontal defects with a nano-HA paste leads to significantly improved clinical outcomes when compared with papilla preservation flap surgery alone.

Keywords

Nanostructured hydroxyapatite Grafts Intrabony defects Periodontal regeneration Periodontal diseases 

Notes

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Cortellini P, Tonetti MS (2000) Focus on intrabony defects: guided tissue regeneration. Periodontol 2000 22:104–132CrossRefPubMedGoogle Scholar
  2. 2.
    Hiatt WH, Schallhorn RG (1973) Intraoral transplants of cancellous bone and marrow in periodontal lesions. J Periodontol 44:194–208PubMedGoogle Scholar
  3. 3.
    Lekovic V, Kenney EB, Carranza FA, Danilovic V (1990) Treatment of class II furcation defects using porous hydroxyapatite in conjunction with a polytetrafluoroethylene membrane. J Periodontol 61:575–578PubMedGoogle Scholar
  4. 4.
    Lynch SE, de Castilla GR, Williams RC, Kiritsy CP, Howell TH, Reddy MS, Antoniades HN (1991) The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol 62:458–467CrossRefPubMedGoogle Scholar
  5. 5.
    McClain PK, Schallhorn RG (1993) Long term assessment of combined osseous composite grafting, root conditioning, and guided tissue regeneration. Int J Periodontics Restorative Dent 13:9–27PubMedGoogle Scholar
  6. 6.
    Mellonig JT, Bowers GM, Cotton WR (1981) Comparison of bone graft materials. J Periodontol 52:297–301PubMedGoogle Scholar
  7. 7.
    Froum SJ, Kushner L, Scopp IW, Stahl SS (1982) Human clinical and histologic responses to Durapatite implants in intraosseous lesions. Case reports. J Periodontol 53:719–725PubMedGoogle Scholar
  8. 8.
    Baldock WT, Hutchens LH Jr, McFall WT Jr, Simpson DM (1985) An evaluation of tricalcium phosphate implants in human periodontal osseous defects of two patients. J Periodontol 56:1–7PubMedGoogle Scholar
  9. 9.
    Tamai N, Myoui A, Tomita T, Nakase T, Tanaka J, Ochi T, Yoshikawa H (2002) Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo. J Biomed Mater Res 59:110–117CrossRefPubMedGoogle Scholar
  10. 10.
    Hing KA, Best SM, Tanner KE, Bonfield W, Revell PA (1997) Biomechanical assessment of bone ingrowth in porous hydroxyapatite. J Mater Sci Mater Med 8:731–736CrossRefPubMedGoogle Scholar
  11. 11.
    Meffert RM, Thomas JR, Hamilton KM, Brownstein CN (1985) Hydroxylapatite as an alloplastic graft in the treatment of human periodontal osseous defects. J Periodontol 56:63–73PubMedGoogle Scholar
  12. 12.
    Moskow BS, Lubarr A (1983) Histological assessment of human periodontal defect after durapatite ceramic implant. Report of a case. J Periodontol 54:455–462PubMedGoogle Scholar
  13. 13.
    Bezrukov VM, Grigor’iants LA, Zuev VP, Pankratov AS (1998) The surgical treatment of jaw cysts using hydroxyapatite with an ultrahigh degree of dispersity. Stomatologiia (Mosk) 77:31–35Google Scholar
  14. 14.
    Thorwarth M, Schultze-Mosgau S, Kessler P, Wiltfang J, Schlegel KA (2005) Bone regeneration in osseous defects using a resorbable nanoparticular hydroxyapatite. J Oral Maxillofac Surg 63:1626–1633CrossRefPubMedGoogle Scholar
  15. 15.
    Huber FX, Mcarthur N, Hillmeier J, Kock HJ, Baier M, Diwo M, Berger I, Meeder PJ (2006) Void filling of tibia compression fracture zones using a novel resorbable nanocrystalline hydroxyapatite paste in combination with a hydroxyapatite ceramic core: first clinical results. Arch Orthop Trauma Surg 126:533–540CrossRefPubMedGoogle Scholar
  16. 16.
    Grigor’ian AS, Grigor’iants LA, Podoinikova MN (2000) A comparative analysis of the efficacy of different types of filling materials in the surgical elimination of tooth perforations (experimental morphological research). Stomatologiia (Mosk) 79:9–12Google Scholar
  17. 17.
    Gerlach KL, Niehues D (2007) Treatment of jaw cysts with a new kind of nanoparticular hydroxylapatite. Mund Kiefer Gesichtschir 11:131–137CrossRefPubMedGoogle Scholar
  18. 18.
    Schwarz F, Bieling K, Latz T, Nuesry E, Becker J (2006) Healing of intrabony peri-implantitis defects following application of a nanocyrstalline hydroxyapatite (Ostim™) or a bovine-derived xenograft (Bio-Oss™) in combination with a collagen membrane (Bio-Gide™). A case series. J Clin Periodontol 33:491–499CrossRefPubMedGoogle Scholar
  19. 19.
    Kasaj A, Röhrig B, Zafiropoulos GG, Willershausen B (2008) Clinical evaluation of nanocrystalline hydroxyapatite paste in the treatment of human periodontal bony defects—a randomized controlled clinical trial: 6-month results. J Periodontol 79:394–400CrossRefPubMedGoogle Scholar
  20. 20.
    Zuev VP, Dmitrieva LA, Pankratov AS, Filatova NA (1996) The comparative characteristics of stimulators of reparative osteogenesis in the treatment of periodontal diseases. Stomatologiia (Mosk) 75:31–34Google Scholar
  21. 21.
    Cortellini P, Pini Prato GP, Tonetti M (1999) The simplified papilla preservation flap. A novel surgical approach for the management of soft tissues in regenerative procedures. Int J Periodontics Restorative Dent 19:589–599PubMedGoogle Scholar
  22. 22.
    Cortellini P, Pini Prato GP, Tonetti M (1995) The modified papilla preservation technique. A new surgical approach for interproximal regenerative procedures. J Periodontol 66:217–223Google Scholar
  23. 23.
    Hujoel PP, Moulton LH (1988) Evaluation of test statistics in split-mouth clinical trials. J Periodontal Res 23:378–380CrossRefPubMedGoogle Scholar
  24. 24.
    Needleman I, Tucker R, Giedrys-Leeper E, Worthington H (2005) Guided tissue regeneration for periodontal intrabony defects—a cochrane systematic review. Periodontol 37:106–123CrossRefGoogle Scholar
  25. 25.
    Jeffcoat M, Jeffcoat RL, Jens SC, Captain K (1986) A new periodontal probe with automated cemento-enamel junction design. J Clin Periodontol 13:276–280CrossRefPubMedGoogle Scholar
  26. 26.
    Persson GR (1991) Effects of line-angle versus midproximal periodontal probing measurements on prevalence estimates of periodontal disease. J Periodontal Res 26:527–529CrossRefPubMedGoogle Scholar
  27. 27.
    Zybutz M, Rapoport D, Laurell L, Persson GR (2000) Comparisons of clinical and radiographic measurements of inter-proximal vertical defects before and 1 year after surgical treatments. J Clin Periodontol 27:179–186CrossRefPubMedGoogle Scholar
  28. 28.
    Wachtel H, Schenk G, Böhm S, Weng D, Zuhr O, Hürzeler MB (2003) Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study. J Clin Periodontol 30:496–504CrossRefPubMedGoogle Scholar
  29. 29.
    Trombelli L, Bottega S, Zucchelli G (2002) Supracrestal soft tissue preservation with enamel matrix proteins in the treatment of deep intrabony defects. A report of 35 consecutively treated cases. J Clin Periodontol 29:433–439CrossRefPubMedGoogle Scholar
  30. 30.
    Kasaj A, Willershausen B, Reichert C, Gortan-Kasaj A, Zafiropoulos GG, Schmidt M (2008) Human periodontal fibroblast response to a nanostructured hydroxyapatite bone replacement graft in vitro. Arch Oral Biol 53:683–689CrossRefPubMedGoogle Scholar
  31. 31.
    Reynolds MA, Aichelmann-Reidy ME, Branch-Mays GL, Gunsolley JC (2003) The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review. Ann Periodontol 8:227–265CrossRefPubMedGoogle Scholar
  32. 32.
    Kenney EB, Lekovic V, Han T, Carranza FA Jr, Dimitrijevic B (1985) The use of porous hydroxylapatite (HA) implant in periodontal defects. I. Clinical results after six months. J Periodontol 56:82–88PubMedGoogle Scholar
  33. 33.
    Trombelli L, Heitz-Mayfield L, Needleman I, Moles D, Scabbia A (2002) A systematic review of graft materials and biological agents for periodontal intraosseous defects. J Clin Periodontol 29:117–135CrossRefPubMedGoogle Scholar
  34. 34.
    Stahl SS, Froum SJ (1987) Histologic and clinical responses to porous hydroxylapatite implants in human periodontal defects. Three to twelve months postimplantation. J Periodontol 58:689–695PubMedGoogle Scholar
  35. 35.
    Bauer TW, Muschler GF (2000) Bone graft materials. An overview of the basic science. Clin Orthop Relat Res 371:10–27CrossRefPubMedGoogle Scholar
  36. 36.
    Horvath A, Stavropoulos A, Sculean A (2009) Clinical and histological evaluation of human intrabony periodontal defects treated with an unsintered nanocrystalline hydroxyapatite paste (Ostim®). J Clin Periodontol 36:116Google Scholar
  37. 37.
    Sun W, Chu C, Wang J, Zhao H (2007) Comparison of periodontal ligament cells responses to dense and nanophase hydroxyapatite. J Mater Sci Mater Med 18:677–683CrossRefPubMedGoogle Scholar
  38. 38.
    Schnettler R, Dingeldein E (2002) Inorganic bone substitutes. In: Lewandrowski KU, Wise DL, Trantolo DJ, Gresser JD, Yaszemski MJ, Altobelli DE (eds) Tissue engineering and biodegradable equivalents: scientific and clinical applications. Marcell Dekker, Inc., New York, pp 401–432Google Scholar
  39. 39.
    Chris Arts JJ, Verdonschot N, Schreurs BW, Buma P (2006) The use of a bioresorbable nano-crystalline hydroxyapatite paste in acetabular bone impaction grafting. Biomaterials 27:1110–1118CrossRefPubMedGoogle Scholar
  40. 40.
    Schnettler R, Stahl JP, Alt V, Pavlidis T, Dingeldein E, Wenisch S (2004) Calcium phosphate-based bone substitutes. Eur J Trauma 4:219–229Google Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Bernd Heinz
    • 1
  • Adrian Kasaj
    • 2
  • Marie Teich
    • 1
  • Søren Jepsen
    • 3
    Email author
  1. 1.HamburgGermany
  2. 2.Department of Operative Dentistry and PeriodontologyJohannes Gutenberg-UniversityMainzGermany
  3. 3.Department of Periodontology, Operative and Preventive DentistryUniversity of BonnBonnGermany

Personalised recommendations